Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Chondrosarcoma, Mesenchymal × Trabectedin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 14 Ovarian Neoplasms 6 Neoplasms 5 Liposarcoma 5 Leiomyosarcoma 5 Liposarcoma, Myxoid 3 Breast Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Prostatic Neoplasms 2 Osteosarcoma 2 Neoplasms by Site 2 Neoplasm Metastasis 2 Mesothelioma, Malignant 2 Ichthyosis, X-Linked 2 Endometrial Neoplasms 2 Uterine Neoplasms 1 Solitary Fibrous Tumors 1 Soft Tissue Neoplasms 1 Skin Diseases 1 Sarcoma, Synovial 1 Sarcoma, Endometrial Stromal 1 Sarcoma, Alveolar Soft Part 1 Recurrent High Grade Meningioma 1 Pancreatic Neoplasms 1 Ovarian Diseases 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Mesothelioma 1 Malignant mesenchymal tumor 1

Interventions

regorafenib 1 Trabectedin 1 Sirolimus 1 Pharmacogenomic Testing 1 HhAntag691 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04305548 2026-03-27

ISG-MCS

Italian Sarcoma Group

Phase 2 Recruiting

Chondrosarcoma, Mesenchymal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡